Aspire Biopharma has partnered with Microsize to advance the development of a new sublingual powder formulation of alprazolam.

Esperion is to acquire Corstasis Therapeutics to expand its cardiovascular franchise with the addition of Enbumyst, a ...

Partnering with a US-based CDMO can offer many advantages for pharmaceutical companies looking to the US market.

OSE will now pivot to focus on late-stage pipeline development of its cancer vaccine, Tedopi and its anti-inflammatory drug, lusvertikimab.

New drugs and lucrative markets in the US remain crucial to Europe’s pharma sector, as governments approach closer trade with ...

US-based biotechnology company Rallybio has entered a definitive agreement to acquire Candid Therapeutics through a merger transaction.

Kairos Pharma has signed a binding agreement to acquire exclusive worldwide rights to CL-273 from Celyn Therapeutics.

If approved, Moderna's mCOMBRIAX would become the first combination Covid-flu jab to gain regulatory approval anywhere across ...

The EMA's CHMP has issued a positive opinion recommending the approval of Dupixent in the EU for paediatric patients with CSU ...

BioMarin’s Voxzogo (vosoritide) won FDA approval in paediatric achondroplasia in November 2021 and secured a label extension ...

BioMarin Pharmaceutical has received FDA approval for its sBLA for Palynziq’s use in adolescents aged 12 years and above with ...